Literature DB >> 12499736

Are "micrometastases" of the peritoneum equivalent to distant metastases?

Peter Kienle1, Moritz Koch.   

Abstract

Tumor progression after curative resection of gastrointestinal cancer is probably caused by disseminated tumor cells that can be detected in different body compartments, e.g. the peritoneum. The clinical importance and prognostic significance of gross peritoneal metastasis is well known whereas the prognostic relevance of disseminated tumor cells in the peritoneum of patients with gastrointestinal cancer is still unclear. Disseminated tumor cells in the peritoneal cavity are generally detected by cytology, immunohistochemistry or polymerase chain reaction-based molecular methods. A consensus on the most adequate detection method has not yet been found making the comparison of different data difficult. The prognostic relevance of tumor cell dissemination has, at least in part, been shown for gastric, pancreatic and colon cancer, and the prognostic data regarding gastric cancer are most convincing. Peritoneal "micrometastases" are obviously not equivalent to distant metastases as the evidence for their prognostic significance is clearly less than that for gross peritoneal metastases. This article gives a critical review of the detection and prognostic significance of disseminated tumor cells in the peritoneum of patients with gastrointestinal cancer. Copyright 2002 S. Karger AG, Basel

Entities:  

Mesh:

Year:  2002        PMID: 12499736     DOI: 10.1159/000067609

Source DB:  PubMed          Journal:  Dig Surg        ISSN: 0253-4886            Impact factor:   2.588


  3 in total

1.  Clinical implications of peritoneal cytology in potentially resectable pancreatic cancer: positive peritoneal cytology may not confer an adverse prognosis.

Authors:  Suguru Yamada; Shin Takeda; Tsutomu Fujii; Shuji Nomoto; Naohito Kanazumi; Hiroyuki Sugimoto; Hideki Kasuya; Yasuhiro Kodera; Tetsuro Nagasaka; Satoshi Morita; Akimasa Nakao
Journal:  Ann Surg       Date:  2007-08       Impact factor: 12.969

2.  Clinical significance of telomerase activity in peritoneal disseminated cells: gastrointestinal cancers.

Authors:  Inna L Botchkina; David E Rivadeneira; Kevin Watkins; Martin S Karpeh; Galina I Botchkina
Journal:  Mol Med       Date:  2008 Jan-Feb       Impact factor: 6.354

3.  The Comparison of mDCF and mFOLFOX-6 as First-Line Treatment in Metastatic Gastric Cancer.

Authors:  Yusuf Acikgoz; Selin Aktürk Esen; Gokhan Ucar; Merve Dirikoc; Yakup Ergun; Oznur Bal; Dogan Uncu
Journal:  Cureus       Date:  2021-05-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.